Trial Profile
Comparison of the Effects of Photodynamic Therapy, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Verteporfin
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 14 Mar 2018 New trial record